Presbyopia Clinical Trial
Verified date | August 2017 |
Source | Johnson & Johnson Vision Care, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to evaluate the effect of a multi-focal contact lens on symptomatic patients.
Status | Completed |
Enrollment | 49 |
Est. completion date | December 1, 2009 |
Est. primary completion date | December 1, 2009 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 35 Years to 47 Years |
Eligibility |
Inclusion Criteria: - To have signed an informed consent form (documented by the investigator in the Case Report Form [CRF]). - Be existing daily wear spherical single-vision soft CL wearers (no extended wear in the last 3 months, but silicone hydrogels in daily wear are allowed). - Between 35 and 47 years of age (inclusive). - Have a CL spherical distance requirement between -1.00D and -6.00D (-6.50D refractive) in both eyes. - Refractive astigmatism of 0.75D or less in both eyes. - Visual symptoms associated with near vision - Be correctable to a visual acuity of 6/9 (20/30) or better in each eye. - Have normal eyes with no evidence of abnormality or disease. For the purpose of this study a normal eye is defined as one having: 1. No amblyopia. 2. No evidence of lid abnormality or infection. 3. No conjunctival abnormality or infection. 4. No clinically significant slit lamp findings (i.e. stromal haze, staining, scarring, Vascularization, infiltrates or abnormal opacities). 5. No other active ocular disease. Exclusion Criteria: - Monovision user or multifocal CL wearer. - Regular user of reading spectacles (i.e. daily usage). - Requires concurrent ocular medication. - Clinically significant (Grade 3 or 4) corneal stromal haze, corneal Vascularization, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate CL wear. - Corneal staining Grade 3 in more than two regions. - Has had any anterior ocular surgery. Has had any other ocular surgery or injury within 8 weeks immediately prior to enrollment for this study. - Pre-existing ocular irritation that would preclude CL fitting. - Keratoconus or other corneal irregularity. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Johnson & Johnson Vision Care, Inc. | Visioncare Research Ltd. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Subject Reported Overall Vision Quality Using (CLUE)TM Questionnaire | The Contact Lens User Experience (CLUE) Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response, with scores ranging from 0-120. | week 4 | |
Primary | Monocular Amplitude of Accommodation | The amplitude of accommodation is a measure of the eyes ability to accommodate or focus on near objects. The method used was the push-up/push-down method performed monocularly. One eye was occluded and using the smallest print the subject was able to read, the reading chart was slowly moved towards the subject. The subject was asked them to indicate when the print first becomes blurred. The distance was noted and the amplitude of accommodation was calculated. | week 4 | |
Secondary | Proportion of Subjects With Near Vision Symptoms as Assessed by the NVQ | Proportion of subjects reporting frequent/constant near vision problem per the Near Vision Questionnaire (NVQ). The NVQ was used to assess subjects' near vision problems. Subjects graded each question using a 5-level Likert-type scale (5-levels: never, infrequent, sometimes, frequently, constantly). | week 4 | |
Secondary | Subject Reported Lens Comfort Using CLUE Questionnaire | Subject reported lens comfort was assessed using the CLUE Questionnaire. CLUE is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response. Scores range from 0 -120. | week 4 | |
Secondary | Comfortable Wearing Time | Comfortable wearing time was measured using self-reported subject awareness of irritation at a given time of day, rounded to the nearest half-hour. Could be described as aware of issue or completely comfortable. | week 4 | |
Secondary | Proportion of Subjects Benefiting From the Binocular +/-1.00D Accommodative Flipper | Utility of the use of the Binocular +/-1.00D accommodative flipper as a screening tool for those emerging presbyopia subjects | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05326607 -
Pilot Clinical Investigation of Adaptative Eyeglasses for the Correction of Presbyopia
|
N/A | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Completed |
NCT05495971 -
Extended Depth of Focus Contact Lenses for Presbyopia
|
N/A | |
Completed |
NCT05464732 -
Vivity IOL: Emmetropia Compared to Monovision.
|
N/A | |
Recruiting |
NCT06045299 -
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
|
Phase 3 | |
Active, not recruiting |
NCT04151550 -
Safety & Efficacy of the Laser Scleral Microporation Procedure (Philippines)
|
N/A | |
Not yet recruiting |
NCT05506553 -
Comparison of Aspheric Toric Intraocular Lenses for Micro-monovision
|
N/A | |
Completed |
NCT02554396 -
Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
|
Phase 2 | |
Completed |
NCT02214797 -
Dispensing Study to Assess Visual Performance of Prototype Contact Lenses
|
N/A | |
Completed |
NCT02235831 -
DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance
|
N/A | |
Enrolling by invitation |
NCT01443585 -
Clinical Evaluation of a Progressive Addition Lens (PAL)
|
N/A | |
Completed |
NCT01591499 -
Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision Multifocal
|
N/A | |
Completed |
NCT04983589 -
A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily
|
Phase 3 | |
Completed |
NCT02740010 -
The Visual Performances of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus
|
||
Recruiting |
NCT05796453 -
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
|
N/A | |
Completed |
NCT02516306 -
A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia
|
Phase 1/Phase 2 | |
Completed |
NCT05359380 -
The Impact of Light Conditions on the Efficacy of Multifocal Intraocular Lens Implantation in Activities of Daily Living
|
||
Not yet recruiting |
NCT04522427 -
Study of Presbyopia-correcting Intraocular Lenses in Eyes With Previous Corneal Refractive Surgery
|
N/A | |
Completed |
NCT03688425 -
Comparison of Clinical Outcomes POD L GF vs POD F GF in Asian Eyes
|
N/A | |
Recruiting |
NCT06053463 -
Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers
|
N/A |